Long Ran

Institution
University of Science and Technology of China

Country
China

Field
Chemistry

Long won the 2017 L’Oréal UNESCO For Women in Science International Rising Talent award for her research on photocatalysts for carbon dioxide reduction.

(Photo: L’oréal Foundation)

AWARDS
  • 2017 LOréal-UNESCO For Women in Science International Rising Talent Award

Related articles

Study Shows That Daily Sunscreen Use Prevents Skin Aging

An Australian study has revealed that daily use of broad spectrum sunscreen slows down the aging process of skin, as well as preventing skin cancer.

Fujifilm & Dr. Reddy’s Call Off Generic Drugs Joint Venture In Japan

FUJIFILM and Dr. Reddy's Laboratories have terminated an MOU to enter into a joint venture for the Japanese generics drugs market.

World First Hand, Foot And Mouth Vaccine Developed

Chinese researchers have developed the world's first ever vaccine against a strain of enterovirus that can cause hand, foot and mouth disease,

EBOS Group Limited Acquires Australian Pharma Distributor, Symbion

EBOS Group Limited announced this week details of a NZ$1.1 billion acquisition of Australia's Symbion.

Amgen & Astellas Enter Into Japan Alliance

Amgen and Astellas Pharma Inc. today announced a strategic alliance to co-develop and co-commercialize new medicines in Japan.

Agilent, University Of Rouen, A*STAR To Collaborate In Glycomics

Agilent, the University of Rouen, and A*STAR have signed an MOU to develop tools to effectively analyze biologics and vaccines.

NTU Medical School To Use Plastinated Human Bodies Instead Of Cadavers

Nanyang Technological University's new medical school will be pioneering the use of plastinated bodies for its anatomy classes.

Is The Asian Space Science Drive Harming Development?

Are the large sums of money invested into building prestigious space programs diverting funding from key areas such as health and education?

India Develops First Indigenous Rotavirus Vaccine

The Government of India and Bharat Biotech have announced positive Phase III results from India's first indigenous, low-priced rotavirus vaccine.